|Articles|April 30, 2018
Syneos Health Launches Catalyst Ophthalmology Site Network
Advertisement
Syneos Health, a biopharmaceutical solutions organization, announced the launch of the Company’s Catalyst Ophthalmology Site Network, the newest therapeutic Network in the Syneos Health Catalyst Site Program which will combine their total to over 100 sites within the program.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA and EMA Align on Ten Principles to Guide Artificial Intelligence Use in Drug Development
2
New Phase II Data Suggest Maternal Nipocalimab Does Not Disrupt Infant Immune Development in Severe HDFN
3
Clinical Operations Teams Adjust to Evidence and Engagement Gaps
4
De-Risking Development: Prioritizing Robustness in Trial Design
5